This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine's Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
Marcel Bonnici named CEO of Ferrara Calcio after Joseph Portelli purchase
The Italian side, formerly known as SPAL, used to compete in Serie A.
Silvano Azzopardi appointed to Board of Directors of Global Legal Entity Identifier Foundation
GLEIF had been set up and tasked with developing a universal identifier for legal entities involved in financial transactions.
HSBC Malta CEO: Innovation and investment key to sustaining Malta’s economic success
He noted that Malta's economy expanded by 4% in 2025 and is forecast to grow by around 3.7% in 2026, ...
Graziella Grech: Efficient hiring of third-country talent is key to Malta’s competitiveness
'The most significant challenge is predictability.'
